CHEMICAL DENATURATION FOR OLIGONUCLEOTIDE ANALYSIS

    公开(公告)号:US20230136953A1

    公开(公告)日:2023-05-04

    申请号:US17976030

    申请日:2022-10-28

    摘要: The present disclosure provides compositions and methods for sample processing, particularly for oligonucleotide analysis e.g. analysis of formulated nucleic acid drugs. A composition for pretreating at least one target nucleic acid in a biological mixture provided herein includes a chaotropic agent selected from a substituted guanidine, a substituted amidine, a substituted quaternary amine, or a combination thereof, an optional protease, and/or an optional disulfide-reducing agent. Methods of analyzing at least one target nucleic acid in a biological mixture is also provided herein. Furthermore, the present disclosure provides methods for quantifying at least one target cationic lipid interacting with a nucleic acid.

    SAMPLE PREPARATION FOR LC-MS BASED SEQUENCE MAPPING OF NUCLEIC ACIDS

    公开(公告)号:US20230111049A1

    公开(公告)日:2023-04-13

    申请号:US17961061

    申请日:2022-10-06

    IPC分类号: C12Q1/6872

    摘要: Methods for quenching a nuclease digestion of a target nucleic acid prior to downstream analysis of the target nucleic acid are disclosed herein. Particularly, methods for controlling the end point of a nuclease digestion prior to sequence analysis of a target nucleic acid is provided. Quenching of a nuclease digestion in the present disclosure employs at least one non-ionic or anionic denaturant combined with an optional reducing agent. The methods presented in this disclosure aids preserving the sample comprising the target nucleic acid or fragments thereof for long term storage and ensures that the effect of contaminating nucleases is eliminated during pretreatment step.

    MODULAR SAMPLE PREPARATION DEVICES AND METHODS

    公开(公告)号:US20210245150A1

    公开(公告)日:2021-08-12

    申请号:US17166051

    申请日:2021-02-03

    IPC分类号: B01L3/00 B01L3/02

    摘要: The present technology relates to a customizable sample preparation device (e.g., liquid sample preparation device, such as a purification, clean-up, or separation device). In particular, the present technology relates to customizable devices formed from modular segments tailored to address one or more of the following: to optimize different sample and elution volumes, to incorporate various connection mechanisms to liquid handlers, to incorporate various liquid dispensing flow conditions, and to fulfill broad applications through the selection of specific resin for sample preparation. Some embodiments are directed to affinity capture devices, such as for example, Protein A affinity capture devices, utilizing a polymethacrylate-based resin. Other resins as well as other materials for processing a liquid sample are described herein.